semaglutide sglt2 inhibitor Inhibitors in the Management of Cardio-Renal-Metabolic Syndrome: A New Therapeutic Era Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors:

Glutathione in Traditional Medicine

CB1 in non-incretin approach Last month Novo Nordisk announced results from a phase 2a with monlunabant, a small molecule oral cannabinoid receptor 1 (CB1) inverse agonist

These findings highlight the dual anti- and pro-nociceptive roles of BAs, likely regulated via their receptor interactions

I used to think getting weight loss medication would be a total hassleendless doctor visits, waiting rooms, and high costs that made it more trouble than it was worth

Florida Mens Health Center provides personalized mens health consultations and treatment options designed to help patients improve energy, confidence, performance, and overall well-being

Annual Report 2023